The Chk1 inhibitor AZD7762 sensitises p53 mutant breast cancer cells to radiation in vitro and in vivo

Author:            

Publisher: Spandidos Publications

ISSN: 1791-2997

Source: Molecular Medicine Reports, Vol.6, Iss.4, 2012-01, pp. : 897-903

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content